Garlic and dyslipidemia: how a common food may reshape cardiovascular risk profiles

Dyslipidemia remains a central driver of cardiovascular disease, contributing to a growing global burden of morbidity and mortality. In recent years, attention has shifted toward dietary interventions that can complement standard therapy. This meta-analysis evaluates whether garlic, a widely used medicinal food, can meaningfully improve lipid profiles in patients with established dyslipidemia. By focusing exclusively on randomized controlled trials in affected individuals, the findings offer clinically relevant insights into its therapeutic potential.

Across 21 trials involving more than 1600 participants, garlic consumption demonstrated consistent lipid-lowering effects. Total cholesterol, triglycerides, and low-density lipoprotein levels were all significantly reduced, while high-density lipoprotein showed a modest increase. These changes, although moderate, are clinically meaningful, as even small reductions in cholesterol levels are associated with a lower risk of cardiovascular events. Notably, the effect appeared more pronounced in individuals over 50 years of age, suggesting a potential age-related benefit.

The form of garlic also influenced outcomes. Preparations such as garlic oil and extracts showed stronger lipid-lowering effects compared to powdered forms, indicating that bioavailability and compound concentration may play a key role. Mechanistically, garlic appears to act through several pathways, including inhibition of cholesterol synthesis, enhanced bile acid excretion, and reduced oxidative modification of lipoproteins. These combined effects support its role as a multitarget metabolic modulator rather than a single-pathway agent.

From a clinical perspective, garlic may represent a useful adjunct in managing dyslipidemia, particularly for patients seeking non-pharmacological options or additional risk reduction. While it should not replace established therapies, its favorable safety profile and accessibility make it an attractive complementary strategy.

Overall, the evidence suggests that regular garlic intake can contribute to improved lipid control and may support long-term cardiovascular prevention. Further studies are needed to clarify optimal dosing, formulation, and duration of use in diverse patient populations.